Skip to content

Effect of ethanol-sodium citrate solution with heparin for inhibition of related infections of hemodialysis catheters and their dysfunction in patients under chronic hemodialysis

Effect of ethanol-sodium citrate solution with heparin for inhibition of related infections of hemodialysis catheters and their dysfunction in patients under chronic hemodialysis

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20201108049311N6
Enrollment
100
Registered
2022-04-04
Start date
2020-10-31
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter infection in patients undergoing hemodialysis. Infection and inflammatory reaction due to peritoneal dialysis catheter

Interventions

Intervention 1: Intervention group: Ethanol-sodium citrate Shahid Gazi Pharmatheutical company 5000 units as lumen volume (about 4.5 cc) for 6 months. Intervention 2: Control group: Heparin 5000 units

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Consent to participate in the study ESRD diagnosis At least 6 months after dialysis Both genders 18 years and older

Exclusion criteria

Exclusion criteria: ICU patients Patients with acute renal injury who do not require long-term vascular access Patients who had long-term scheduled course of antibiotic treatment who be past more than 4 weeks from the date of insertion of the new catheter. Having an arterial fistula or transplant within 2 months

Design outcomes

Primary

MeasureTime frame
Fever (T>37) and chill and pyosis and redness incidence of catheter position. Timepoint: After clinical trials. Method of measurement: By clinical observations.;Catheter venous blood sample culture. Timepoint: After clinical trials. Method of measurement: Cell culture.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Seyyed Sadredin Rasi Hashemi

Tabriz University of Medical Sciences

S_rasihashemi@yahoo.com+98 41 3336 9331

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026